(2 years, 11 months ago)
Commons ChamberThe hon. Lady is absolutely right. I congratulate her on championing those issues. Many hon. Members raise their harrowing cases of serious road traffic incidents at Justice questions. In addition to the increase from 14 years to life for the offences I referred to, in the Police, Crime, Sentencing and Courts Bill, we are also creating a new offence of causing serious injury by careless driving. In Government amendments, we will increase from two years to five years the minimum period of disqualification from driving for offenders convicted of causing death by dangerous driving or causing death by careless driving when under the influence of drink or drugs. That sends a strong signal that we want to put victims first, which is why we are bringing forward those changes.
We are already seeing the results of our efforts to tackle the impact of the pandemic on our justice system. Outstanding cases in magistrates courts are falling and are close to recovering to pre-pandemic levels. In the Crown court, the backlog is stabilising. The spending review provides an extra £477 million for the criminal justice system, which will allow us to reduce Crown court backlogs caused by the pandemic from about 60,000 today to an estimated 53,000 by March 2025.
What steps is my hon. Friend taking to ensure that evidence is not compromised by the passage of time if there is a delay?
My hon. Friend makes an excellent point. Since 2000, outstanding cases in the Crown court have never been below 30,000, so it is inherent in the criminal justice system that some cases take time. It is important that we consider how to preserve evidence and section 28 is a key part of that. Since November 2020, vulnerable witnesses have had the option to pre-record cross-examination evidence in advance of a trial. In September, we extended the pilot to allow intimidated witnesses to pre-record their cross-examination evidence to a further four Crown courts. We recently set out that we want to go much further and roll it out to all Crown courts.
(8 years, 7 months ago)
Commons ChamberI welcome the Backbench Business Committee’s selection of this important topic, and I congratulate my hon. Friend the Member for Norwich North (Chloe Smith) and the hon. Members for Kingston upon Hull North (Diana Johnson) and for South Down (Ms Ritchie) on their efforts in securing this valuable debate.
I want to acknowledge the tremendous campaigning work of the all-party parliamentary group on haemophilia and contaminated blood. Its efforts have helped to pave the way for the current Department of Health consultation to secure a lasting financial and support settlement for those thousands of people infected with HIV and hepatitis C through contaminated blood in the 1970s and early 1980s.
Let me say at the outset that my heart goes out to those people who have been affected by the contaminated blood scandal, both in my constituency of South East Cornwall and across the country. The devastating impact on patients and their families and friends is immeasurable and lasts for a lifetime. We must all do what we can to ensure that those affected have as secure a future as possible.
I have personal experience of trying to help one constituent who has sadly been impacted by this terrible tragedy. My constituent was infected with contaminated blood in 1985 at the age of 35 and subsequently contracted full blown hepatitis C, which has now developed into cirrhosis of the liver.
My constituent, who understandably has asked not to be identified, has undergone three courses of arduous interferon-based treatment. The last course caused a life-threatening infection that required a month in hospital and some invasive surgery and extensive abdominal surgery.
Now aged 65, my constituent suffers from severe fatigue, physical weakness, brain fog, which means that she is unable to read anything vaguely complicated, constant itching, fever, sweats, depression and total and permanent hair loss. The stress of living with those conditions on a daily basis for 30 years must be immeasurable. The Government must do all they can to support patients and their families.
My constituent wanted me to highlight her case as an example of where anomalies in support for patients suffering from cirrhosis of the liver have led to financial hardship and additional worry at a very distressing time. She was very grateful for the lump sum she received and an income of £14,760 per annum. However, that figure would be £26,000 in Scotland, nearly double the sum offered in England. That is iniquitous.
A constituent of mine—Janis Richards of Sudbury—has written to me, and hers is a very tragic case similar to that highlighted by my hon. Friend. I am struggling to explain to her why there are such different arrangements for constituents across the United Kingdom, given that this problem originally arose under a UK Government.
I completely concur with my hon. Friend. My constituent is particularly concerned about proposals to withdraw index linking from annual income and to refuse to increase it by any meaningful amount. I understand that there is a recommendation to fix annual payments at a flat rate of £15,000 a year, which would leave my constituent with a nominal financial increase of about £240. There are also proposals to withdraw back-up services for emergencies and to withdraw support, which my constituent will certainly require, given the severity of her condition.
May I ask my hon. Friend the Minister to clarify the position, and to take my constituent’s concerns into account when formulating final proposals? My constituent previously enjoyed a successful career in the legal profession, but she became too ill to pursue it after her infection with contaminated blood. Her career was, sadly, cut short, as was her considerable earning potential and professional development.
Patients must be treated with fairness, and each case must be assessed and supported on its merits. I am grateful that the Prime Minister acknowledged the scale of the tragedy and apologised on behalf of the UK Government. I welcome the additional funding for England that was announced in 2015 to ease the transition to a reformed scheme and ensure its sustainable operation with patients at its core. That scheme must provide a robust and fair system that supports and compensates those who are affected and removes any unnecessary complexity and unfairness.